Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Valens Company Inc (The) Ordinary Shares VLNCF

Healthcare Drug Manufacturers - Specialty & Generic Cannabis
The Valens Co Inc is a developer and manufacturer of cannabinoid-based products. The company's extraction methods are CO2, ethanol, hydrocarbon, solvent-less, and terpene extraction. Its products are Tinctures, Capsules, Beverages, and Vape cartridges among others. Its reportable segments are Cannabis operations, Analytical testing, and Corporate. The company has a business presence in Canada... see more

Recent & Breaking News (OTCQX:VLNCF)

The Valens Company Reviews 2021 Milestones & Announces Virtual Investor Day

PR Newswire January 18, 2022

The Valens Company to Participate in ATB Capital Markets' 10th Annual Institutional Investor Conference

PR Newswire January 7, 2022

The Valens Company Enters Manufacturing Partnership with MTL Cannabis for Extraction and Manufacturing of Pre-rolls and Vapes

PR Newswire December 22, 2021

The Valens Company Announces Two Strategic Agreements with PMI Mexico

PR Newswire December 21, 2021

The Valens Company Secures CAD$40 Million Term Loan

PR Newswire December 16, 2021

The Valens Company Commences Trading on Nasdaq Capital Market

PR Newswire December 9, 2021

The Valens Company to Begin Trading on Nasdaq Capital Market

PR Newswire December 8, 2021

Pommies Receives Micro-Processing Licence from Health Canada for Greater Toronto Area Facility

PR Newswire November 22, 2021

Tyler Robson, CEO, Chair and Co-Founder of The Valens Company Honored as Recipient of Canada's Top 40 Under 40® for 2021

PR Newswire November 18, 2021

The Valens Company Announces Next Step Towards Nasdaq Listing

PR Newswire November 15, 2021

The Valens Company (TSX:VLNS) acquires Citizen Stash Cannabis Corp.

John Ballem  November 8, 2021

The Valens Company Completes Acquisition of Leading, Premium Craft Licensed Producer, Citizen Stash Cannabis Corp.

PR Newswire November 8, 2021

Aurora announces manufacturing agreement with The Valens Company

Stockhouse Editorial November 1, 2021

The Valens Company Announces Entry to Québec Market

PR Newswire October 18, 2021

The Valens Company Reports Financial Results for The Third Quarter of Fiscal 2021

PR Newswire October 13, 2021

The Valens Company to Hold Conference Call to Discuss Financial Results for the Third Quarter of 2021

PR Newswire October 7, 2021

The Valens Company Enters into Six Manufacturing Partnerships and Provides Corporate Update

PR Newswire October 5, 2021

The Valens Company Announces Strategic Distribution Agreement with APOTEKA SRL, part of GFI Costa Rica & Provides Australia Update

PR Newswire September 16, 2021